<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0028-3746</journal-id>
<journal-title><![CDATA[Neumología y cirugía de tórax]]></journal-title>
<abbrev-journal-title><![CDATA[Neumol. cir. torax]]></abbrev-journal-title>
<issn>0028-3746</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Neumología y Cirugía de Tórax; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas; Sociedad Cubana de Neumología; Sociedad Paraguaya de Neumología; Sociedad Boliviana de Neumología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0028-37462018000300213</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Paracoccidioidomicosis crónica. ¿Cuándo el compromiso pulmonar aislado debería recibir tratamiento hospitalario? Reporte de caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Chronic Paracoccidioidomycosis with isolated pulmonary involvement, When should be treated in hospital? Case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carreño-Almánzar]]></surname>
<given-names><![CDATA[Fabián Ramiro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Vargas]]></surname>
<given-names><![CDATA[Juan Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fajardo-Rivero]]></surname>
<given-names><![CDATA[Javier Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mantilla-Hernández]]></surname>
<given-names><![CDATA[Julio Cesar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Industrial de Santander Hospital Universitario de Santander ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2018</year>
</pub-date>
<volume>77</volume>
<numero>3</numero>
<fpage>213</fpage>
<lpage>217</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0028-37462018000300213&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0028-37462018000300213&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0028-37462018000300213&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La paracoccidioidomicosis es la micosis sistémica y endémica más importante en Latinoamérica, Colombia es el segundo país con mayor número de casos. De acuerdo con las manifestaciones clínicas, las formas de presentación de esta enfermedad pueden ser aguda o crónica; esta última se presenta en pacientes mayores de 30 años ocasionando compromiso pulmonar, en piel y mucosas. El tratamiento antimicótico se basa en la administración de sulfas y derivados azólicos en casos de manifestaciones leves a moderada, y anfotericina B que se reserva para pacientes con enfermedad grave y requiere manejo intrahospitalario. Se presenta el caso de un paciente de 66 años con manifestaciones pulmonares severas como única manifestación de paracoccidioidomicosis crónica que no respondió inicialmente al manejo con itraconazol oral, por lo que se ofreció manejo con anfotericina B. Ante la ausencia de criterios clínicos claros de hospitalización por compromiso pulmonar, consideramos que el compromiso clínico-radiológico se debe tener en cuenta a la hora de iniciar el manejo parenteral de forma temprana.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Paracoccidioidomycosis is the most important systemic and endemic mycosis in Latin America, Colombia is the second country with the highest number of cases. According to the clinical manifestations, the forms of presentation of this disease can be acute or chronic; the last one occurs in patients older than 30 years causing lung involvement, in skin and mucous membranes. The antifungal treatment is based on the administration of sulfa drugs and azole derivatives in cases of mild to moderate manifestations, and amphotericin B, which is reserved for patients with severe disease and requires in-hospital management. We present the case of a 66-year-old patient with severe pulmonary manifestations as the only manifestation of chronic paracoccidioidomycosis that did not respond initially to management with oral itraconazole, therefore management was offered with amphotericin B. In the absence of clear clinical criteria for hospitalization by pulmonary commitment, we consider that the clinical - radiological commitment must be taken into account when initiating early parenteral management.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Anfotericina B]]></kwd>
<kwd lng="es"><![CDATA[compromiso clínico-radiológico]]></kwd>
<kwd lng="es"><![CDATA[manejo intrahospitalario]]></kwd>
<kwd lng="es"><![CDATA[manifestaciones pulmonares]]></kwd>
<kwd lng="es"><![CDATA[paracoccidioidomicosis crónica]]></kwd>
<kwd lng="en"><![CDATA[Amphotericin B]]></kwd>
<kwd lng="en"><![CDATA[clinical-radiological compromise]]></kwd>
<kwd lng="en"><![CDATA[intrahospital management]]></kwd>
<kwd lng="en"><![CDATA[pulmonary manifestations]]></kwd>
<kwd lng="en"><![CDATA[chronic paracoccidioidomycosis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud y Protección Social</collab>
<source><![CDATA[Sistema integral de información de la protección social (SISPRO)]]></source>
<year></year>
<publisher-name><![CDATA[[Internet]]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torrado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[de la Hoz]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paracoccidioidomicocis: definición de las áreas endémicas de Colombia]]></article-title>
<source><![CDATA[Biomedica]]></source>
<year>2000</year>
<volume>20</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>327-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Queiroz-Telles]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Escuissato]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary paracoccidioidomycosis]]></article-title>
<source><![CDATA[Semin Respir Criti Care Med]]></source>
<year>2011</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>764-74</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El hábitat natural del hongo Paracoccidioides brasiliensis, ¿cómo trazar el límite entre lo rural y lo urbano?]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2014</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Theodoro]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Texeira Mde]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Felipe]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genus paracoccidioides: Species recognition and biogeographic aspects]]></article-title>
<source><![CDATA[PloS One]]></source>
<year>2012</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Niño-Vega]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paracoccidioides Spp.: Virulence factors and immune-evasion strategies]]></article-title>
<source><![CDATA[Mediators Inflamm]]></source>
<year>2017</year>
<numero>2017</numero>
<issue>2017</issue>
<page-range>5313691</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New trends in Paracoccidioidomycosis epidemiology]]></article-title>
<source><![CDATA[J Fungi (Basel)]]></source>
<year>2017</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marques]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating]]></article-title>
<source><![CDATA[An Bras Dermatol]]></source>
<year>2013</year>
<volume>88</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>700-11</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shikanai-Yasuda]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paracoccidioidomycosis treatment]]></article-title>
<source><![CDATA[Rev Inst Med Trop Sao Paulo]]></source>
<year>2015</year>
<volume>57</volume>
<numero>^s19</numero>
<issue>^s19</issue>
<supplement>19</supplement>
<page-range>31-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Prado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Prado]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary paracoccidioidomycosis: radiology and clinical-epidemiological evaluation]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>2010</year>
<volume>43</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>651-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quagliato Júnior]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Grangeia]]></surname>
<given-names><![CDATA[Tde A]]></given-names>
</name>
<name>
<surname><![CDATA[Massucio]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[De Capitani]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Rezende]]></surname>
<given-names><![CDATA[Sde M]]></given-names>
</name>
<name>
<surname><![CDATA[Balthazar]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between paracoccidioidomycosis and tuberculosis: reality and misdiagnosis]]></article-title>
<source><![CDATA[J Bras Pneumol]]></source>
<year>2007</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>295-300</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wingeter]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Svidzinski]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical-radiological dissociation in lung manifestations of paracoccidioidomycosis]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>2008</year>
<volume>41</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>454-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peçanha]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[de Souza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Falqueto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series]]></article-title>
<source><![CDATA[Int J Antimicrob Agents]]></source>
<year>2016</year>
<volume>48</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>428-30</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamaga]]></surname>
<given-names><![CDATA[LYI]]></given-names>
</name>
<name>
<surname><![CDATA[Benard]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[67Ga scintigraphy for assessment of disease severity and treatment response in patients with Paracoccidioidomycosis]]></article-title>
<source><![CDATA[Clin Nucl Med]]></source>
<year>2018</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>305-10</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
